StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.70+0.00 (0.00%)

Close on Nov 17, 2026Market cap $103.06MP/E –Yield –

Unicycive Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Unicycive Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was -3077.6%. For fiscal 2023 it was -3077.6%, against -1898.2% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-3077.6%−1179.4
FY2022Dec 31, 2022-1898.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2023Mar 31, 2023-622.5%–
Q3 FY2022Sep 30, 2022-584.0%–

More Unicycive Therapeutics figures

See a number that looks wrong?